CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Gianluca Baio

OPENALEX: A5023729638↗ORCID: 0000-0003-4314-2570↗

Affiliations

Organizations

Royal Statistical Societyauthorship · GB University College Londonauthorship · GB

Public evidence

2 connected articles

Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder.2023 · Europe PMC Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder.2023 · PubMed Central Open Access

Registered research

Connected studies

A Phase IIa/b, Randomised, Double-blind, Placebo-controlled, Single-site, Parallel Group Clinical Trial to Examine Cannabidiol (CBD) as a Pharmacological Treatment for Cannabis Dependence.nct02044809

Matched by exact identifiers only. Profile data: Corpus/OpenAlex.

Gianluca Baio - Medical Cannabis Research Engine